MedTrace Logo

Long Term Follow-up of Autologous Bone Marrow Mononuclear Cells Therapy in STEMI

NCT00626145 · Status: UNKNOWN · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 37

Last updated 2008-02-29

No results posted yet for this study

Summary

The benefit of current reperfusion therapies for ST-elevation myocardial infarction (STEMI) is limited by post-infarction left ventricular (LV) dysfunction. Many clinic trails showed the short term outcome of bone marrow stem cell transplantation for MI patients, but rare report of long term follow-up results. Our aim was to investigate 4 years' efficacy and LV functional improvement of autologous bone marrow mononuclear cells (BMMC) transplantation in patients with ST-elevation myocardial infarction.

Conditions

Interventions

PROCEDURE

saline infusion

Patients receive intracoronary injections of saline 7 days after PCI.

PROCEDURE

autologous bone marrow mononuclear cells infusion

Patients receive intracoronary injections of autologous bone marrow mononuclear cells 7 days after PCI.

Sponsors & Collaborators

  • Xijing Hospital

    lead OTHER

Principal Investigators

  • Haichang Wang, MD,PHD · Xijing Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
45 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-03-31
Primary Completion
2008-03-31
Completion
2008-03-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00626145 on ClinicalTrials.gov